1188.01USD-2.38%Mkt Cap: 1.06T $P/E: 42.28Today
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, incl…
Industry Peers
Drug Manufacturers - General$618.61BUSDP/E 29.8
$438.31BUSDP/E 121.0
$309.64BUSDP/E 21.3
$305.12BUSDP/E 34.8
$277.04BUSDP/E 22.2
$270.65BUSDP/E 22.0
$247.88BUSDP/E 25.8
$216.35BUSDP/E 25.5
$207.68BUSDP/E 11.8
$196.12BUSDP/E 25.3
$161.19BUSDP/E 17.7
$137.76BUSDP/E 18.5
$117.58BUSDP/E 16.1
$99.17BUSDP/E 19.3
$85.40BUSDP/E 13.8
$29.40BUSDP/E 21.4
MRV
Marvell Technology, Inc.$24.46BUSDP/E 9.3
$11.35BUSDP/E 22.7
$10.67BUSDP/E 18.5
$10.61BUSDP/E 18.4
$6.60BUSDP/E 14.6
$3.55BUSDP/E 14.5
$2.92BUSDP/E 17.8
$66.67MUSD
$38.85MUSD
ELXR
Elixxer Ltd.$9.51MUSD
CELG-RI
Bristol-Myers Squibb Company Ce—
—
FLXN
Horizon Flexible Income ETF—P/E 27.0
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap1.06T $
Enterprise Value1.12T $
Revenue (TTM)72.25B $
Gross Profit54.13B $
Net Income (TTM)20.64B $
Revenue/Share80.61 USD
Last Price1188.01 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees50.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS5324571083
Valuation
P/E (Trailing)42.28
P/E (Forward)27.16
PEG1.55
EV/EBITDA31.02
EV/Revenue15.55
P/S15.02
P/B34.85
EPS (TTM)28.23
EPS (Forward)44.80
52W Range
623.7890% of range1249.45
52W High1249.45 USD
52W Low623.78 USD
Profitability
Gross Margin83.04%
Oper. Margin49.39%
EBITDA Margin50.13%
Profit Margin31.67%
ROE77.78%
ROA18.35%
Growth
Revenue Growth55.50%
Earnings Growth169.90%
Cash Flow & Leverage
Operating CF16.81B $
CapEx (TTM)10.85B $
FCF Margin12.67%
FCF Yield0.86%
Net Debt38.09B $
Net Debt/EBITDA1.05
Balance Sheet
Debt/Equity1.60
Current Ratio1.50
Quick Ratio0.72
Book Value/Sh34.92 USD
Cash/Share5.923 USD
Dividends
Fwd Div Rate6.920 USD
Trail. Div Rate6.230 USD
Div. Yield0.57%
5Y Avg Yield0.89%
Payout Ratio22.13%
Ex-Div DateAug 14, 2026
Pay DateSep 10, 2026
Splits
Last Split2:1
Split DateOct 16, 1997
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1228.25 USD
Upside (mean)+3.4%
Target Range850.00 USD – 1500.00 USD
$850.00+3.4% to mean$1500.00
# Analysts28
Ownership
Shares Out.891.74M
Float889.33M
Insiders0.15%
Institutions85.22%
Short Interest
Short Ratio3.0d
Short % Float1.09%
Short % Out.1.08%
Shares Short9.66M
Short (prev mo.)8.43M
Technical
SMA 501080.46 (+10.0%)
SMA 200994.16 (+19.5%)
Beta0.51
S&P 52W Chg20.11%
Avg Vol (30d)2.60M
Avg Vol (10d)3.39M
Technical Indicators
RSI (14)57.0
MACD36.2275
MACD Signal37.1549
MACD Hist.-0.9274
BB Upper1262.16 USD
BB Middle1165.65 USD
BB Lower1069.15 USD
BB Width16.56%
ATR (14)38.47 USD
Vol Ratio (20d)0.62x